How big is the continuous blood glucose monitoring market today, and what are its future growth expectations?
The continuous blood glucose monitoring market size has grown strongly in recent years. It will grow from $13.57 billion in 2024 to $14.87 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increase in diabetes prevalence, regulatory compliance, demand for remote monitoring, emerging markets, rise in healthcare spending.
The continuous blood glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $23.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to growing aging population, rising home healthcare, telehealth expansion, rise in healthcare expenditure, rise in disposable income. Major trends in the forecast period include wearable integration, artificial intelligence and machine learning, advanced sensors and accuracy, partnerships and collaboration.
Get Your Free Sample of The Global Continuous Blood Glucose Monitoring Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13079&type=smp
What have been the primary factors driving the continuous blood glucose monitoring market’s growth?
The increase in the prevalence of diabetes is expected to propel the growth of the continuous blood glucose monitoring market going forward. Diabetes is a health disease that occurs when the blood glucose levels fluctuate in the body. Blood glucose monitoring devices can aid in the detection of trends and patterns that give a better full picture of a diabetic’s condition. For instance, as of the latest updates, the International Diabetes Federation (IDF) has reported that approximately 537 million adults aged 20 to 79 are currently living with diabetes globally. This figure marks a significant increase from previous estimates and highlights a concerning trend in diabetes prevalence. The IDF predicts that this number will rise to 643 million by 2030, and further to 783 million by 2045. Therefore, the increasing prevalence of diabetes is driving the continuous blood glucose monitoring market growth going forward.
What are the key segments within the continuous blood glucose monitoring market?
The continuous blood glucose monitoring market covered in this report is segmented –
1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers
2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients
3) By End User: Hospitals, Homecare Diagnostics, Other End Users
Subsegments:
1) By Insulin Pumps: Tubeless Insulin Pumps, Tubed Insulin Pumps, Patch Pumps
2) By Sensors: Continuous Glucose Monitoring Sensors, Flash Glucose Monitoring Sensors, Implantable Sensors
3) By Transmitters: Integrated Transmitters, Wireless Transmitters, Bluetooth-enabled Transmitters
4) By Receivers: Standalone Receivers, Smartphone Apps, Integrated Devices
Order your report now for swift delivery
Which key players are shaping the continuous blood glucose monitoring market?
Major companies operating in the continuous blood glucose monitoring market include F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality
Which market trends are set to define the future of the continuous blood glucose monitoring market?
Technological advancements have emerged as a key trend gaining popularity in the continuous blood glucose monitoring market. Major companies operating in the continuous blood glucose monitoring market are focused on developing advanced technological solutions to strengthen their position in the market. For instance, in 2022, Philips expanded its range of home care solutions for patients with chronic obstructive pulmonary disease (COPD) by introducing the BiPAP A40 EFL, a non-invasive ventilator designed to enhance patient comfort and reduce hospital readmissions. This ventilator leverages Philips’ proprietary ExpiraFlow technology, which allows healthcare professionals to automatically detect expiratory flow limitation (EFL) in COPD patients and provide tailored therapy.
What are the major regional insights for the continuous blood glucose monitoring market, and which region holds the top position?
North America was the largest region in the continuous blood glucose monitoring market in 2024. The regions covered in the continous blood glucose monitoring market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Continuous Blood Glucose Monitoring Market Report 2025 Offer?
The continuous blood glucose monitoring market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Continuous Blood Glucose Monitoring (CGM) involves using a sensor under the skin to constantly track glucose levels. It provides real-time data and alerts for high or low glucose, assisting people with diabetes in managing their blood sugar levels more effectively.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13079
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
